UH Real Estate Investment Trust (NGX:UHOMREIT)

Theseus Pharmaceuticals Balance Sheet

Financials in millions NGN. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Property, Plant & Equipment	9,324	9,969	10,039	9,820	9,932	9,932
Cash & Equivalents	1,115	2,088	1,363	535.94	738.36	148.73
Accounts Receivable	193.21	62.07	62.07	64.21	64.07	64.48
Other Receivables	-	41.38	39.29	41.91	35.04	0.34
Investment In Debt and Equity Securities	1,054	405.21	414.82	978.54	534.83	813.1
Other Current Assets	-	61.88	56.79	62.35	53.23	38.32
Other Long-Term Assets	16.11	-	-	-	-	-
Total Assets	11,702	12,628	11,975	11,503	11,358	10,997
Accrued Expenses	1,282	144.59	137.88	130.65	124.03	120.48
Current Unearned Revenue	258.45	1,218	1,083	936.85	991.36	872.22
Other Current Liabilities	-0	569.45	511.73	437.15	329.25	132.51
Long-Term Unearned Revenue	-	8.34	7.66	24.79	10.9	12.95
Other Long-Term Liabilities	0	-	-	-	-	-
Total Liabilities	1,541	1,941	1,740	1,529	1,456	1,138
Common Stock	9,406	9,406	9,406	9,406	9,406	9,406
Retained Earnings	755.41	1,281	828.27	567.21	495.69	452.52
Shareholders' Equity	10,162	10,687	10,235	9,974	9,902	9,859
Total Liabilities & Equity	11,702	12,628	11,975	11,503	11,358	10,997
Net Cash (Debt)	1,115	2,088	1,363	535.94	738.36	148.73
Net Cash (Debt) Growth	-33.54%	53.24%	154.30%	-27.41%	396.44%	-77.17%
Net Cash Per Share	5.94	11.11	7.25	2.85	3.93	0.79
Filing Date Shares Outstanding	187.63	188.13	188.13	188.13	188.13	188.13
Total Common Shares Outstanding	187.63	188.13	188.13	188.13	188.13	188.13
Book Value Per Share	54.16	56.81	54.40	53.02	52.63	52.41
Tangible Book Value	10,162	10,687	10,235	9,974	9,902	9,859
Tangible Book Value Per Share	54.16	56.81	54.40	53.02	52.63	52.41

Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.